3-Pyrrolidinecarboxamide, 1-(7-chloro-1H-indazol-3-yl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-oxo-

Request For Quotation
3-Pyrrolidinecarboxamide, 1-(7-chloro-1H-indazol-3-yl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-oxo- Suppliers list
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Ningbo Chaoming Biotechnology Co., Ltd  
Tel: 13301662590
Email: mandy@atkchemical.com

3-Pyrrolidinecarboxamide, 1-(7-chloro-1H-indazol-3-yl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-oxo- manufacturers
3-Pyrrolidinecarboxamide, 1-(7-chloro-1H-indazol-3-yl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-oxo- Basic information
Product Name:3-Pyrrolidinecarboxamide, 1-(7-chloro-1H-indazol-3-yl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-oxo-
Synonyms:3-Pyrrolidinecarboxamide, 1-(7-chloro-1H-indazol-3-yl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-oxo-;PAC1R antagonist 1;N-[2-(1H-imidazol-4-yl)ethyl]-1-(7-chloro-1H-indazol-3-yl)-5-oxo-3-pyrrolidinecarboxamide;PA-915
CAS:2305204-24-2
MF:C17H17ClN6O2
MW:372.81
EINECS:
Product Categories:
Mol File:2305204-24-2.mol
3-Pyrrolidinecarboxamide, 1-(7-chloro-1H-indazol-3-yl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-oxo- Structure
3-Pyrrolidinecarboxamide, 1-(7-chloro-1H-indazol-3-yl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-oxo- Chemical Properties
Boiling point 895.2±65.0 °C(Predicted)
density 1.510±0.06 g/cm3(Predicted)
pka11.26±0.40(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
3-Pyrrolidinecarboxamide, 1-(7-chloro-1H-indazol-3-yl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-oxo- Usage And Synthesis
UsesPAC1R antagonist 1 (compound 3d) is a potent and orally active antagonist of PAC1 receptor. PAC1R antagonist 1 can inhibit pituitary adenylate cyclase-activating polypeptide (PACAP)- and nerve injury-induced allodynia[1].
References[1] Takasaki I, et, al. Synthesis of a novel and potent small-molecule antagonist of PAC1 receptor for the treatment of neuropathic pain. Eur J Med Chem. 2020 Jan 15;186:111902. DOI:10.1016/j.ejmech.2019.111902
3-Pyrrolidinecarboxamide, 1-(7-chloro-1H-indazol-3-yl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-oxo- Preparation Products And Raw materials
Tag:3-Pyrrolidinecarboxamide, 1-(7-chloro-1H-indazol-3-yl)-N-[2-(1H-imidazol-5-yl)ethyl]-5-oxo-(2305204-24-2) Related Product Information
PG 97-269 Anti-PACAP-38 antibody [D-p-Cl-Phe6,Leu17]-VIP TFA Benzoic acid, 3-[4-[(4-carboxy-3-methoxy-2,5,6-trimethylphenoxy)carbonyl]-3-methoxy-2,5,6-trimethylphenoxy]-4,6-dihydroxy-2,5-dimethyl-, 1-[4-[(4-carboxy-3-methoxy-2,5,6-trimethylphenoxy)carbonyl]-3-methoxy-2,5,6-trimethylphenyl] ester peptide histidine valine 42 PACAP (1-38), amide, Biotin-labeled